Detection of biological threat agents by real-time PCR: Comparison of assay performance on the RAPID, the LightCycler, and the smart cycler platforms

被引:82
作者
Christensen, DR [1 ]
Hartman, LJ [1 ]
Loveless, BM [1 ]
Frye, MS [1 ]
Shipley, MA [1 ]
Bridge, DL [1 ]
Richards, MJ [1 ]
Kaplan, RS [1 ]
Garrison, J [1 ]
Baldwin, CD [1 ]
Kulesh, DA [1 ]
Norwood, DA [1 ]
机构
[1] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA
关键词
D O I
10.1373/clinchem.2005.052522
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Rapid detection of biological threat agents is critical for timely therapeutic administration. Fluorogenic PCR provides a rapid, sensitive, and specific tool for molecular identification of these agents. We compared the performance of assays for 7 biological threat agents on the Idaho Technology, Inc. R.A.P.I.D.(R), the Roche LightCycler (R), and the Cepheid Smart Cycle (R). Methods: Real-time PCR primers and dual-labeled fluorogenic probes were designed to detect Bacillus anthracis, Brucella species, Clostridium botulinum, Coxiella burnetii, Francisella tularensis, Staphylococcus aureus, and Yersinia pestis. DNA amplification assays were optimized by use of Idaho Technology buffers and deoxynucleotide triphosphates supplemented with Invitrogen Platinum (R) Taq DNA polymerase, and were subsequently tested for sensitivity and specificity on the R.A.P.I.D., the LightCycler, and the Smart Cycler. Results: Limit of detection experiments indicated that assay performance was comparable among the platforms tested. Exclusivity and inclusivity testing with a general bacterial nucleic acid cross-reactivity panel containing 60 DNAs and agent-specific panels containing nearest neighbors for the organisms of interest indicated that all assays were specific for their intended targets. Conclusion: With minor supplementation, such as the addition of Smart Cycler Additive Reagent to the Idaho Technology buffers, assays for DNA templates from biological threat agents demonstrated similar performance, sensitivity, and specificity on all 3 platforms. (c) 2006 American Association for Clinical Chemistry.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 32 条
[1]   Molecular beacons as diagnostic tools: Technology and applications [J].
Abravaya, K ;
Huff, J ;
Marshall, R ;
Merchant, B ;
Mullen, C ;
Schneider, G ;
Robinson, J .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) :468-474
[2]   Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder [J].
Afonina, I ;
Zivarts, M ;
Kutyavin, I ;
Lukhtanov, E ;
Gamper, H ;
Meyer, RB .
NUCLEIC ACIDS RESEARCH, 1997, 25 (13) :2657-2660
[3]   Regulation of gonadotropin gene expression by Mullerian inhibiting substance [J].
Bédécarrats, GY ;
O'Neill, FH ;
Norwitz, ER ;
Kaiser, UB ;
Teixeira, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9348-9353
[4]   DIFFERENTIATION OF BRUCELLA-ABORTUS-BV-1, BRUCELLA-ABORTUS-BV-2, AND BRUCELLA-ABORTUS-BV-4, BRUCELLA-MELITENSIS, BRUCELLA-OVIS, AND BRUCELLA-SUIS-BV-1 BY PCR [J].
BRICKER, BJ ;
HALLING, SM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (11) :2660-2666
[5]   A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml [J].
Collins, ML ;
Irvine, B ;
Tyner, D ;
Fine, E ;
Zayati, C ;
Chang, CA ;
Horn, T ;
Ahle, D ;
Detmer, J ;
Shen, LP ;
Kolberg, J ;
Bushnell, S ;
Urdea, MS ;
Ho, DD .
NUCLEIC ACIDS RESEARCH, 1997, 25 (15) :2979-2984
[6]   Comparative analysis of the Schleicher and Schuell IsoCode Stix DNA isolation device and the Qiagen QIAamp DNA mini kit [J].
Coyne, SR ;
Craw, PD ;
Norwood, DA ;
Ulrich, MP .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) :4859-4862
[7]   Anthrax [J].
Dixon, TC ;
Meselson, M ;
Guillemin, J ;
Hanna, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :815-826
[8]   Sensitivity of multiplex real-time PCR reactions, using the LightCycler and the ABI PRISM 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase [J].
Exner, MM ;
Lewinski, MA .
MOLECULAR AND CELLULAR PROBES, 2002, 16 (05) :351-357
[9]   Clinical recognition and management of patients exposed to biological warfare agents [J].
Franz, DR ;
Jahrling, PB ;
Friedlander, AM ;
McClain, DJ ;
Hoover, DL ;
Bryne, WR ;
Pavlin, JA ;
Christopher, CW ;
Eitzen, EM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (05) :399-411
[10]   Development of a novel internal positive control for Taqman® based assays [J].
Hartman, LJ ;
Coyne, SR ;
Norwood, DA .
MOLECULAR AND CELLULAR PROBES, 2005, 19 (01) :51-59